Search

Teva has recently launched teriparatide injection, a generic version of Forteo. This injection is used to treat postmenopausal women with osteoporosis who are at a higher risk for fractures or who cannot tolerate other osteoporosis treatments. It can reduce the risk of fractures in the spine and other bones. Additionally, it is indicated to increase bone mass in men with primary or hypogonadal osteoporosis who are at a high risk for fractures, as well as in both men and women with osteoporosis caused by glucocorticoid medicines. For more information, visit tevapharm.com. [Extracted from the article]

The article focuses on a study which examined the effects of teriparatide on bone mineral density and bone strength in patients with mild osteogenesis imperfecta.

The article focuses on modification made to peptide's backbone of osteoporosis medicine teriparatide by Samuel H. Gellman of the University of Wisconsin in Madison, Wisconsin and Thomas J. Gardella of Harvard Medical School by replacing α-amino acids to improve half life of the drug.

The article focuses on a study conducted by doctors Elaina Barraza and Pablo Pazmino regarding injection of teriparatide, which could prevent and heal bone fractures in patients with osteoporosis.